Fig. 4.
(A) Immunoblot analysis of TOPO II and β levels using serum IID (15) in control (C) and RA (R)-treated HL-60 cells. (B) Analysis of TOPO II and β protein levels by measurement of optical density.
(A) Immunoblot analysis of TOPO II and β levels using serum IID (15) in control (C) and RA (R)-treated HL-60 cells. (B) Analysis of TOPO II and β protein levels by measurement of optical density.
